FDA warns about unapproved medications from a Canadian supplier

FDA warns about unapproved medications from a Canadian supplier

The U. S. Food & Drug Administration (FDA) has warned more than 350 medical practices that they might have received unapproved, counterfeit or unsafe medications from a Canadian supplier.

The federal food and drugs regulator said that the medications, including unapproved variants of Botox, could harm patients as they could be counterfeit or contaminated.

The foreign supplier who allegedly supplied the unapproved medications to the U. S. medical practices is operated by Canada Drugs, which is also called Quality Specialty Products (QSP), QP Medical or Bridgewater Medical.

In the letter written to the medical practices, the federal agency said, "FDA is very concerned that products distributed by these suppliers may cause harm to patients, because they may be unsafe or ineffective."

The FDA also warned doctors about purchasing drugs from any source other than pharmacies licensed by the U. S. authorities.

Dr. Peter B. Fodor, a plastic surgeon and an expert on Botox, also warned that using a non-FDA approved Botox could be very dangerous.

This is the fifth warning issued by the FDA this year about a foreign supplier supplying unapproved medications.

 

General: 
Region: 
Companies: 

Popular Stories

Try drug-free remedies before resorting to medication for low back pain: ACP

People suffering low back pain should try drug-free... Read More

Pregnant inmate forced to deliver baby on jail cell floor

A Detroit-area sheriff has defended his staff over... Read More

Marathon Pharma to sell decades-old drug to treat DMD for $89,000

Marathon Pharmaceuticals will reportedly market... Read More

CDC updates 2017 advisory for recommended flu shots

An advisory board of the U.S. Centers for Disease... Read More